Nestorone
CAS No. 7759-35-5
Nestorone( Elcometrine | Nestorone | ST-1435 | ST1435 )
Catalog No. M15930 CAS No. 7759-35-5
Nestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 51 | In Stock |
|
25MG | 106 | In Stock |
|
50MG | 203 | In Stock |
|
100MG | 329 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNestorone
-
NoteResearch use only, not for human use.
-
Brief DescriptionNestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.
-
DescriptionNestoron2 (ST1435, Elcometrine) is a 19-norprogesterone derivative and steroidal progestin which is used as a hormonal contraceptive, a high-affinity agonist of the progesterone receptor.Other Indication Discontinued(In Vivo):Nestoron (400 μCi 3H Nestoron/kg BW; subcutaneous injection; female Sprague-Dawley rats) treatment results in the Cmax in the blood and plasma are 58.1 and 95.5 ng equiv. 3H Nestoron/g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose is excreted via feces and urine, respectively.
-
In Vitro——
-
In VivoNestoron (400 μCi 3H Nestoron/kg BW; subcutaneous injection; female Sprague-Dawley rats) treatment results in the Cmax in the blood and plasma are 58.1 and 95.5 ng equiv. 3H Nestoron/g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose is excreted via feces and urine, respectively. Animal Model:27 adult, female, Sprague-Dawley rats (200-225 g; age: 8 weeks)Dosage:400 μCi 3H Nestorone/kg BWAdministration:Subcutaneous injection (Pharmacokinetic study)Result:The mean peak concentrations of radioactivity (Cmax) in the blood and plasma were 58.1 and 95.5 ng equiv./g, with t1/2 of 15.6 hours. Approximately, 81.4% and 7.62% of the administered dose was excreted via feces and urine, respectively.
-
SynonymsElcometrine | Nestorone | ST-1435 | ST1435
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorPR
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number7759-35-5
-
Formula Weight370.4819
-
Molecular FormulaC23H30O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC([C@@]1(OC(C)=O)C(C[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O)=C)=O
-
Chemical Name19-Norpregn-4-ene-3,20-dione, 17-(acetyloxy)-16-methylene-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. L?hteenm?ki P, et al. Contraception. 1981 Jan;23(1):63-75.
2. Suhonen S, et al. Fertil Steril. 1992 Jun;57(6):1211-5.
3. Coutinho EM, et al. Contraception. 1999 Feb;59(2):115-22.
molnova catalog
related products
-
Terutroban
Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.
-
MF-766
MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. It behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. It can be used for cancer and inflammation diseases research.
-
Evatanepag
Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.